Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of Cellular Physiology
|
April 21, 2011
Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells
Sanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity
Mingzhu He, Kai Fan Cheng, Sonya VanPatten, et al.
Molecular Cancer Therapeutics
|
March 19, 2008
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
Danijela Maksimovic-Ivanic, Sanja Mijatovic, Ljubica Harhaji, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 4, 2011
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity
Yousef Al-Abed, Christine N Metz, Kai Fan Cheng, et al.
Brain, Behavior, and Immunity
|
July 27, 2014
Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation
Mauricio Rosas-Ballina, Sergio I Valdés-Ferrer, Meghan E Dancho, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 13, 2019
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Huan Yang, Hui Liu, Qiong Zeng, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Novel small-molecule inhibitors of the protein kinase DYRK: Potential therapeutic candidates in cancer
Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg, et al.
Cell Chemical Biology
|
June 10, 2026
Small-molecule inhibitors of the protein kinase DYRK as potential therapeutic candidates in cancer
Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg, et al.
Nitric Oxide : Biology and Chemistry
|
May 8, 2008
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
Sanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
Danijela Maksimovic-Ivanic, Sanja Mijatovic, Djordje Miljkovic, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of Cellular Physiology
|
April 21, 2011
Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells
Sanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity
Mingzhu He, Kai Fan Cheng, Sonya VanPatten, et al.
Molecular Cancer Therapeutics
|
March 19, 2008
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
Danijela Maksimovic-Ivanic, Sanja Mijatovic, Ljubica Harhaji, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 4, 2011
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity
Yousef Al-Abed, Christine N Metz, Kai Fan Cheng, et al.
Brain, Behavior, and Immunity
|
July 27, 2014
Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation
Mauricio Rosas-Ballina, Sergio I Valdés-Ferrer, Meghan E Dancho, et al.
Molecular Medicine (Cambridge, Mass.)
|
April 13, 2019
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
Huan Yang, Hui Liu, Qiong Zeng, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Novel small-molecule inhibitors of the protein kinase DYRK: Potential therapeutic candidates in cancer
Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg, et al.
Cell Chemical Biology
|
June 10, 2026
Small-molecule inhibitors of the protein kinase DYRK as potential therapeutic candidates in cancer
Prabhadevi Venkataramani, Elad Elkayam, Ankur Garg, et al.
Nitric Oxide : Biology and Chemistry
|
May 8, 2008
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
Sanja Mijatovic, Danijela Maksimovic-Ivanic, Marija Mojic, et al.
Molecular Cancer Therapeutics
|
May 7, 2009
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
Danijela Maksimovic-Ivanic, Sanja Mijatovic, Djordje Miljkovic, et al.
Page
of 4